Analystreport

Horizon Pharma PLC (NASDAQ: HZNP) was upgraded by analysts at Citigroup Inc from a "neutral" rating to a "buy" rating.

Horizon Therapeutics Public Limited Company - Ordinary Shares  (HZNP) 
Last horizon therapeutics public limited company - ordinary shares earnings: 2/26 07:00 am Check Earnings Report